Department of Orthopaedic Surgery and Traumatology, Marmara University, School of Medicine, İstanbul, Turkey.
Acta Orthop Traumatol Turc. 2021 Mar;55(2):159-165. doi: 10.5152/j.aott.2021.20130.
This study aimed to assess the pain and functional status of patients who underwent various surgical interventions for the stabilization of selected multiple myeloma (MM) lesions in the extremities and pelvis and to investigate the rate of complications requiring reintervention.
Patients with MM who underwent various surgical interventions for the extremity or pelvic lesions were retrospectively reviewed. Change in the pain intensity was assessed using visual analogous scale (VAS) preoperatively, at the time of discharge, and at the final follow-up. Functional status was assessed using the musculoskeletal tumor society (MSTS) scoring system for both upper and lower extremities preoperatively and at the final follow-up. Postoperative complications requiring reintervention, including dislocation, loss of fixation/aseptic loosening of prosthesis, mechanical insufficiency, periprosthetic fracture, infection, or progression of the local disease, were recorded.
A total of 49 (20 men and 29 women) previously (23) or newly (26) diagnosed patients with a mean age of 60.8±18.2 years were included in this study. Of these, 6 patients underwent multiple surgeries for different skeletal sites; in total, 57 procedures were performed. The mean follow-up was 47.7±21.63 months. The lesions were localized to the humerus (19), radius (1), pelvis (4), femur (30), and tibia (3). The surgical indications included therapy-refractory pain for 17 patients and pathological fractures due to progression of pre-existing lesions for 12 patients or newly diagnosed lesions with extensive bone destruction at initial presentation for 28 patients. Surgical procedures included prosthetic reconstruction in 32 patients, cement-augmented osteosynthesis in 9, and closed intramedullary nailing in 16. The mean VAS score decreased from 8.75±1.2 preoperatively to 3.21±1.56 at the time of discharge and 1.2±0.42 at the final follow-up. Although a significant decrease was detected between the preoperative and postoperative VAS scores at the time of discharge (p=0.0001), the decrease between the time of discharge and the final follow-up was statistically insignificant (p=0.086). The mean MSTS score significantly improved from 9.1%±6.4% (range: 0%-40%) preoperatively to 76%±14.9% (range: 40%-93.3%) at the final follow-up (p=0.0001). Significantly higher MSTS scores were obtained in the upper extremity than lower extremity/pelvis (p=0.04) and in isolated diaphyseal involvement than metaphyseal or articular involvement (p=0.032). A total of 11 complications requiring reintervention (19.2%) were observed, which included dislocation (3.5%), loss of fixation (5.2%), mechanical insufficiency (3.5%), infection (5.2%), and local tumor progression (1.7%). The rate of complications requiring reintervention was lower but statistically insignificant in the upper extremity (5%; 1/20) than lower extremity/pelvis (27%; 10/37) (p=0.076) and in isolated diaphyseal involvement (6.2%; 1/16) than metaphyseal or articular involvement (24.3%; 10/41) (p=0.079).
Although different types of surgeries can achieve pain relief and good function in different anatomical localizations, better functional results with lower complication rates may be obtained following surgical management of MM lesions in the upper extremities and in diaphyseal localizations.
Level IV, Therapeutic Study.
本研究旨在评估因多发性骨髓瘤(MM)病变而分别接受各种手术干预以稳定四肢和骨盆的患者的疼痛和功能状态,并调查需要再次干预的并发症发生率。
回顾性分析了因四肢或骨盆病变而接受各种手术干预的 MM 患者。使用视觉模拟量表(VAS)评估术前、出院时和最终随访时的疼痛强度变化。使用肌肉骨骼肿瘤学会(MSTS)评分系统评估术前和最终随访时上下肢的功能状态。记录需要再次干预的术后并发症,包括脱位、假体固定丢失/无菌性松动、机械功能不全、假体周围骨折、感染或局部疾病进展。
共纳入 49 例(20 名男性和 29 名女性)患者,其中 23 例为先前诊断,26 例为新诊断,平均年龄为 60.8±18.2 岁。其中 6 例患者因不同骨骼部位进行了多次手术;总共进行了 57 次手术。平均随访时间为 47.7±21.63 个月。病变部位位于肱骨(19 例)、桡骨(1 例)、骨盆(4 例)、股骨(30 例)和胫骨(3 例)。手术指征包括 17 例因治疗抵抗性疼痛,12 例因原有病变进展导致病理性骨折,或 28 例因初诊时广泛骨破坏而新诊断的病变。手术包括假体重建 32 例,骨水泥增强骨固定 9 例,闭合髓内钉固定 16 例。VAS 评分平均从术前的 8.75±1.2 分降至出院时的 3.21±1.56 分,最终随访时的 1.2±0.42 分。虽然出院时 VAS 评分与术前相比显著降低(p=0.0001),但出院时与最终随访时之间的差异无统计学意义(p=0.086)。MSTS 评分平均从术前的 9.1%±6.4%(范围:0%-40%)显著提高到最终随访时的 76%±14.9%(范围:40%-93.3%)(p=0.0001)。上肢 MSTS 评分显著高于下肢/骨盆(p=0.04)和骨干受累高于干骺端或关节受累(p=0.032)。共观察到 11 例(19.2%)需要再次干预的并发症,包括脱位(3.5%)、固定丢失(5.2%)、机械功能不全(3.5%)、感染(5.2%)和局部肿瘤进展(1.7%)。再次干预的并发症发生率较低,但无统计学意义,上肢(5%;1/20)低于下肢/骨盆(27%;10/37)(p=0.076),骨干受累低于干骺端或关节受累(6.2%;1/16)(p=0.079)。
尽管不同类型的手术可以在不同的解剖部位实现缓解疼痛和良好的功能,但在上肢和骨干部位进行 MM 病变的手术治疗可能会获得更好的功能结果和较低的并发症发生率。
IV 级,治疗研究。